Track the Onconetix, Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Market capitalisation: €1.2m. The latest transaction was reported on 25 March 2025 (Attribution). Among the most active insiders: Bruhlmann Christian. The full history is openly available.
11
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Onconetix, Inc. is a company listed on the XNAS market, specializing in the development of innovative solutions for cancer diagnostics. It focuses on improving early detection methods for oncological diseases.